Cargando…
Adenovirus and miRNAs()
Adenovirus infection has a tremendous impact on the cellular silencing machinery. Adenoviruses express high amounts of non-coding virus associated (VA) RNAs able to saturate key factors of the RNA interference (RNAi) processing pathway, such as Exportin 5 and Dicer. Furthermore, a proportion of VA R...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102710/ https://www.ncbi.nlm.nih.gov/pubmed/21621026 http://dx.doi.org/10.1016/j.bbagrm.2011.05.004 |
_version_ | 1783511892342341632 |
---|---|
author | Carnero, Elena Sutherland, James D. Fortes, Puri |
author_facet | Carnero, Elena Sutherland, James D. Fortes, Puri |
author_sort | Carnero, Elena |
collection | PubMed |
description | Adenovirus infection has a tremendous impact on the cellular silencing machinery. Adenoviruses express high amounts of non-coding virus associated (VA) RNAs able to saturate key factors of the RNA interference (RNAi) processing pathway, such as Exportin 5 and Dicer. Furthermore, a proportion of VA RNAs is cleaved by Dicer into viral microRNAs (mivaRNAs) that can saturate Argonaute, an essential protein for miRNA function. Thus, processing and function of cellular miRNAs is blocked in adenoviral-infected cells. However, viral miRNAs actively target the expression of cellular genes involved in relevant functions such as cell proliferation, DNA repair or RNA regulation. Interestingly, the cellular silencing machinery is active at early times post-infection and can be used to control the adenovirus cell cycle. This is relevant for therapeutic purposes against adenoviral infections or when recombinant adenoviruses are used as vectors for gene therapy. Manipulation of the viral genome allows the use of adenoviral vectors to express therapeutic miRNAs or to be silenced by the RNAi machinery leading to safer vectors with a specific tropism. This article is part of a "Special Issue entitled:MicroRNAs in viral gene regulation". |
format | Online Article Text |
id | pubmed-7102710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71027102020-03-31 Adenovirus and miRNAs() Carnero, Elena Sutherland, James D. Fortes, Puri Biochim Biophys Acta Gene Regul Mech Article Adenovirus infection has a tremendous impact on the cellular silencing machinery. Adenoviruses express high amounts of non-coding virus associated (VA) RNAs able to saturate key factors of the RNA interference (RNAi) processing pathway, such as Exportin 5 and Dicer. Furthermore, a proportion of VA RNAs is cleaved by Dicer into viral microRNAs (mivaRNAs) that can saturate Argonaute, an essential protein for miRNA function. Thus, processing and function of cellular miRNAs is blocked in adenoviral-infected cells. However, viral miRNAs actively target the expression of cellular genes involved in relevant functions such as cell proliferation, DNA repair or RNA regulation. Interestingly, the cellular silencing machinery is active at early times post-infection and can be used to control the adenovirus cell cycle. This is relevant for therapeutic purposes against adenoviral infections or when recombinant adenoviruses are used as vectors for gene therapy. Manipulation of the viral genome allows the use of adenoviral vectors to express therapeutic miRNAs or to be silenced by the RNAi machinery leading to safer vectors with a specific tropism. This article is part of a "Special Issue entitled:MicroRNAs in viral gene regulation". Elsevier B.V. 2011 2011-05-17 /pmc/articles/PMC7102710/ /pubmed/21621026 http://dx.doi.org/10.1016/j.bbagrm.2011.05.004 Text en Copyright © 2011 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Carnero, Elena Sutherland, James D. Fortes, Puri Adenovirus and miRNAs() |
title | Adenovirus and miRNAs() |
title_full | Adenovirus and miRNAs() |
title_fullStr | Adenovirus and miRNAs() |
title_full_unstemmed | Adenovirus and miRNAs() |
title_short | Adenovirus and miRNAs() |
title_sort | adenovirus and mirnas() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102710/ https://www.ncbi.nlm.nih.gov/pubmed/21621026 http://dx.doi.org/10.1016/j.bbagrm.2011.05.004 |
work_keys_str_mv | AT carneroelena adenovirusandmirnas AT sutherlandjamesd adenovirusandmirnas AT fortespuri adenovirusandmirnas |